SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease 2019 (COVID-19) and/or Vaccination in Nursing Homes

Clinical trial NCT04964024 · COMPLETED

Trial details

NCT number: NCT04964024
Sponsor: Central Hospital, Nancy, France
Status: COMPLETED
Study type: OBSERVATIONAL

COVID-19 Infection

Start date: 2021-07-15
Primary completion: 2022-05-15
Enrollment: 1293

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.